Activin and Inhibin

IM156 (HL156A: HL271 acetate), a chemical derivative of Metformin ( HY-B0627 ), is a potent and orally active AMPK activator that increases AMPK phosphorylation. IM156 attenuates aging-associated cognitive impairment in animal model IM156 is a

IM156 (HL156A: HL271 acetate), a chemical derivative of Metformin ( HY-B0627 ), is a potent and orally active AMPK activator that increases AMPK phosphorylation. IM156 attenuates aging-associated cognitive impairment in animal model IM156 is a

IM156 (HL156A: HL271 acetate), a chemical derivative of Metformin ( HY-B0627 ), is a potent and orally active AMPK activator that increases AMPK phosphorylation. IM156 attenuates aging-associated cognitive impairment in animal model IM156 is a

IM156 (HL156A: HL271 acetate), a chemical derivative of Metformin ( HY-B0627 ), is a potent and orally active AMPK activator that increases AMPK phosphorylation. IM156 attenuates aging-associated cognitive impairment in animal model IM156 is a

IM156 (HL156A: HL271 acetate), a chemical derivative of Metformin ( HY-B0627 ), is a potent and orally active AMPK activator that increases AMPK phosphorylation. IM156 attenuates aging-associated cognitive impairment in animal model IM156 is a

IM156 (HL156A: HL271 acetate), a chemical derivative of Metformin ( HY-B0627 ), is a potent and orally active AMPK activator that increases AMPK phosphorylation. IM156 attenuates aging-associated cognitive impairment in animal model IM156 is a

IMD-0560 is a novel IκB kinase β inhibitor.In VitroPretreatment with IMD-0560 inhibits both IκBα degradation and p65 phosphorylation induced by TNFα. IMD-0560 also suppresses TNFα-induced transcriptional activity. Pretreatment with IMD-0560 strongly

IMD-0560 is a novel IκB kinase β inhibitor.In VitroPretreatment with IMD-0560 inhibits both IκBα degradation and p65 phosphorylation induced by TNFα. IMD-0560 also suppresses TNFα-induced transcriptional activity. Pretreatment with IMD-0560 strongly

IMD-0560 is a novel IκB kinase β inhibitor.In VitroPretreatment with IMD-0560 inhibits both IκBα degradation and p65 phosphorylation induced by TNFα. IMD-0560 also suppresses TNFα-induced transcriptional activity. Pretreatment with IMD-0560 strongly

IMD-0560 is a novel IκB kinase β inhibitor.In VitroPretreatment with IMD-0560 inhibits both IκBα degradation and p65 phosphorylation induced by TNFα. IMD-0560 also suppresses TNFα-induced transcriptional activity. Pretreatment with IMD-0560 strongly

IMD-0560 is a novel IκB kinase β inhibitor.In VitroPretreatment with IMD-0560 inhibits both IκBα degradation and p65 phosphorylation induced by TNFα. IMD-0560 also suppresses TNFα-induced transcriptional activity. Pretreatment with IMD-0560 strongly

iMDK is a potent PI3K inhibitor and inhibits the growth factor MDK (also known as midkine or MK). iMDK suppresses non-small cell lung cancer (NSCLC) cooperatively with A MEK inhibitor without harming normal cells and mice.In VitroiMDK (50–500 nM)